DISCOVERING TYROSINASE INHIBITORS FROM MORUS SP. PLANTS: AN IN SILICO STUDY
DOI:
https://doi.org/10.22159/ijap.2022.v14s4.PP30%20Keywords:
Morus sp., Melanogenesis, Tyrosinase, Tyrosinase-related protein, In silico, IsorhamnetinAbstract
Objective: This study aimed to examine Morus sp. compounds bonding mode with critical amino acid residues in the binding pocket of the enzyme TRP1 in In silico so that it can be used as a support in the design of skin-lightening cosmetics based on Morus sp.
Methods: Docking is done using autodock tools software, chem office 2019, ChemDraw professional 12, autodock 4.2, discovery studio 2016.
Results: Isorhamnetin has two hydrogen bonds to amino acids Met215 and Asn205. Other compounds found in Morus sp., which have hydrogen bonds with Asn205, are dihydromorin, kaempferol, quercitrin, rutin, and morusin.
Conclusion: Isorhamnetin has the best potential among other compounds as a tyrosinase inhibitor by hydrogen binding to the amino acid Met215, and Asn205 has a free energy of-6.16 kcal/mol.
Downloads
References
Serre C, Busuttil V, Botto JM. Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. Int J Cosmet Sci. 2018 Aug;40(4):328-47. doi: 10.1111/ics.12466, PMID 29752874.
Zolghadri S, Bahrami A, Hassan Khan MT, Munoz Munoz J, Garcia Molina F, Garcia Canovas F. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2019 Jan 1;34(1):279-309. doi: 10.1080/14756366.2018.1545767, PMID 30734608.
de Freitas MM, Fontes PR, Souza PM, William Fagg C, Neves Silva Guerra E, de Medeiros Nobrega YK. Extracts of morus nigra L. leaves standardized in chlorogenic acid, rutin and isoquercitrin: tyrosinase inhibition and cytotoxicity. PLOS One. 2016;11(9):e0163130. doi: 10.1371/journal.pone.0163130. PMID 27655047.
Kumari S, Tien Guan Thng S, Kumar Verma N, Gautam HK. Melanogenesis inhibitors. Acta Derm Venereol. 2018;98(10):924-31. doi: 10.2340/00015555-3002, PMID 29972222.
Deri B, Kanteev M, Goldfeder M, Lecina D, Guallar V, Adir N. The unravelling of the complex pattern of tyrosinase inhibition. Sci Rep. 2016 Dec 11;6(1):34993. doi: 10.1038/srep34993, PMID 27725765.
Falya Y, Firmansyah D, Saptarini NM, Andriani Y, Sumiwi SA, Levita J. The active site of human tyrosinase-related protein: can it be inhibited by plants? J Adv Pharm Educ Res. 2021;11(1):86-90. doi: 10.51847/Oa8F56Q.
Desmedt B, Courselle P, De Beer JO, Rogiers V, Grosber M, Deconinck E. Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe. J Eur Acad Dermatol Venereol. 2016 Jun;30(6):943-50. doi: 10.1111/jdv.13595, PMID 26953335.
Phacharapiyangkul N, Thirapanmethee K, Sa-Ngiamsuntorn K, Panich U, Lee CH, Chomnawang MT. Effect of sucrier banana peel extracts on inhibition of melanogenesis through the ERK signaling pathway. Int J Med Sci. 2019;16(4):602-6. doi: 10.7150/ijms.32137, PMID 31171912.
Wibowo S, Widyarti S, Sabarudin A, Soeatmadji DW, Sumitro SB. The role of astaxanthin compared with metformin in preventing glycated human serum albumin from possible unfolding: A molecular dynamic study. Asian J Pharm Clin Res. 2019 Aug 21:276-82. doi: 10.22159/ajpcr.2019.v12i9.34617.
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009 Dec;30(16):2785-91. doi: 10.1002/jcc.21256, PMID 19399780.
Kontoyianni M, McClellan LM, Sokol GS. Evaluation of docking performance: comparative data on docking algorithms. J Med Chem. 2004 Jan 1;47(3):558-65. doi: 10.1021/jm0302997, PMID 14736237.
Kim R, Skolnick J. Assessment of programs for ligand binding affinity prediction. J Comput Chem. 2008 Jun;29(8):1316-31. doi: 10.1002/jcc.20893, PMID 18172838.
Cardoso R, Valente R, Souza da Costa CH, Gonçalves Vianez da S JL, Santana da Costa K, de Molfetta FA. Analysis of kojic acid derivatives as competitive inhibitors of tyrosinase: a molecular modeling approach. Molecules. 2021 May 12;26(10):2875. doi: 10.3390/molecules26102875.
Wang JY, Chen H, Wang YY, Wang XQ, Chen HY, Zhang M. Network pharmacological mechanisms of vernonia anthelmintica (L.) in the treatment of vitiligo: isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes. BMC Syst Biol. 2017 Dec 16;11(1):103. doi: 10.1186/s12918-017-0486-1, PMID 29145845.
Gong G, Guan YY, Zhang ZL, Rahman K, Wang SJ, Zhou S. Isorhamnetin: a review of pharmacological effects. Biomed Pharmacother. 2020 Aug;128:110301. doi: 10.1016/j.biopha. 2020.110301. PMID 32502837.
Published
How to Cite
Issue
Section
Copyright (c) 2022 YUNIARTI FALYA, RENNY AMELIA, YAYAN RIZIKIYAN, LELA SULASTRI, NUR RAHMI HIDAYATI
This work is licensed under a Creative Commons Attribution 4.0 International License.
